Caricamento...
Gabapentin enacarbil for antipsychotic induced akathisia in schizophrenia patients: a pilot open-labeled study
OBJECTIVE: Gabapentin and its prodrug are candidate therapeutic agents for akathisia. An open-label pilot study was conducted to investigate the therapeutic potential of gabapentin enacarbil (GE) for akathisia. METHODS: In an open-labeled investigator-initiated clinical trial, nine outpatients with...
Salvato in:
| Pubblicato in: | Neuropsychiatr Dis Treat |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Dove Medical Press
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6257366/ https://ncbi.nlm.nih.gov/pubmed/30538475 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S184081 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|